Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

Phase 2

Completed

Conditions: Triple-negative Breast Cancer
Estrogen Receptor-negative Breast Cancer
HER2-negative Breast Cancer
Progesterone Receptor-negative Breast Cancer
Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation
Biological: bevacizumab
Drug: erlotinib hydrochloride

First Posted Date: 2008-08-13

Last Posted Date: 2018-12-04

Lead Sponsor: University of Washington

Target Recruit Count: 59

Registration Number: NCT00733408

Locations: 🇺🇸
Anchorage Oncology Centre, Anchorage, Alaska, United States
🇺🇸
Katmai Oncology Group, Anchorage, Alaska, United States
🇺🇸
Providence Alaska Medical Center, Anchorage, Alaska, United States

and more 14 locations

CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells and HDL-C in Men

Phase 2

Completed

Conditions: Healthy

Interventions: Drug: Acyline + testosterone gel + anastrozole
Drug: Acyline
Drug: Acyline + Testosterone gel

First Posted Date: 2008-08-08

Last Posted Date: 2012-10-12

Lead Sponsor: University of Washington

Target Recruit Count: 31

Registration Number: NCT00729859

A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation

Phase 4

Completed

Conditions: Genital Herpes

Interventions: Drug: acyclovir

First Posted Date: 2008-07-28

Last Posted Date: 2017-03-09

Lead Sponsor: University of Washington

Target Recruit Count: 48

Registration Number: NCT00723229

Locations: 🇺🇸
University of Washington Virology Research Clinic, Seattle, Washington, United States

ICU Family Communication Study

Phase 3

Completed

Conditions: Anxiety
ICU Hospitalization
Depressive Symptoms
Stress Disorders, Post-Traumatic
Depression
Care and Treatment in ICU

Interventions: Behavioral: Usual Care
Behavioral: Facilitator-Based intervention

First Posted Date: 2008-07-22

Last Posted Date: 2014-09-16

Lead Sponsor: University of Washington

Target Recruit Count: 593

Registration Number: NCT00720200

Locations: 🇺🇸
Valley Medical Center, Renton, Washington, United States
🇺🇸
Harborview Medical Center, Seattle, Washington, United States

Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication

Phase 4

Completed

Conditions: Coronary Artery Disease
Carotid Artery Diseases
Atherosclerosis

Interventions: Drug: Atorvastatin
Drug: Placebo Niacin
Drug: Niacin
Drug: Placebo Colesevelam
Drug: Colesevelam

First Posted Date: 2008-07-15

Last Posted Date: 2022-06-07

Lead Sponsor: University of Washington

Target Recruit Count: 217

Registration Number: NCT00715273

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
St. Luke's Idaho Cardiology, Boise, Idaho, United States
🇺🇸
University of Washington Coronary Atherosclerosis Research Lab, Seattle, Washington, United States

and more 1 locations

Cognitive Testing for the Pain Quality Assessment Scale (PQAS)

Completed

Conditions: Pain
Spinal Cord Injuries
Multiple Sclerosis

First Posted Date: 2008-07-15

Last Posted Date: 2012-05-09

Lead Sponsor: University of Washington

Target Recruit Count: 213

Registration Number: NCT00715598

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Video/Audio Distraction Analgesia for Simulated Oncology Procedure Pain

Not Applicable

Completed

Conditions: Pain

Interventions: Procedure: Virtual Reality distraction

First Posted Date: 2008-06-19

Last Posted Date: 2011-09-13

Lead Sponsor: University of Washington

Target Recruit Count: 180

Registration Number: NCT00701571

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Flumazenil Reversal of Oral Triazolam

Phase 1

Completed

Conditions: Dental Anxiety

Interventions: Drug: Placebo
Drug: Flumazenil

First Posted Date: 2008-06-12

Last Posted Date: 2008-06-12

Lead Sponsor: University of Washington

Target Recruit Count: 14

Registration Number: NCT00695630

Locations: 🇺🇸
Dental Fears Research Clinic, Seattle, Washington, United States

Telephone Intervention for Caregivers of Persons With Traumatic Brain Injury

Phase 2

Completed

Conditions: Brain Injuries

Interventions: Behavioral: Problem-solving, education based telephone counseling
Other: No Intervention

First Posted Date: 2008-06-06

Last Posted Date: 2014-04-14

Lead Sponsor: University of Washington

Target Recruit Count: 153

Registration Number: NCT00692575

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Topical Application of MyoRx (Omega 3 Fatty Acids Containing) Cream

Phase 1

Completed

Conditions: Myofacial Pain

Interventions: Drug: MyoRx Cream (6% Omega 3 Fatty Acid)
Drug: Placebo cream, no Omega 3 fatty acid

First Posted Date: 2008-06-04

Last Posted Date: 2008-12-09

Lead Sponsor: University of Washington

Target Recruit Count: 40

Registration Number: NCT00690625

Locations: 🇺🇸
University of Washington, Medical center, Department of Oral Medicine, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy